IMGT (XKRX:456570) EV-to-EBIT : 7.81 (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is IMGT EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, IMGT's Enterprise Value is ₩49,999.60 Mil. IMGT's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩6,403.40 Mil. Therefore, IMGT's EV-to-EBIT for today is 7.81.

The historical rank and industry rank for IMGT's EV-to-EBIT or its related term are showing as below:

XKRX:456570' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.68 Med: 9.55 Max: 17.18
Current: 7.78

During the past 4 years, the highest EV-to-EBIT of IMGT was 17.18. The lowest was 5.68. And the median was 9.55.

XKRX:456570's EV-to-EBIT is ranked better than
55.69% of 422 companies
in the Biotechnology industry
Industry Median: 10.345 vs XKRX:456570: 7.78

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. IMGT's Enterprise Value for the quarter that ended in Dec. 2023 was ₩32,136.00 Mil. IMGT's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩6,403.40 Mil. IMGT's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 19.93%.

IMGT EV-to-EBIT Historical Data

The historical data trend for IMGT's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT EV-to-EBIT Chart

IMGT Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

5.02

IMGT Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT	-	-	-	5.02

Competitive Comparison of IMGT's EV-to-EBIT

For the Biotechnology subindustry, IMGT's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IMGT's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMGT's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where IMGT's EV-to-EBIT falls into.

IMGT EV-to-EBIT Calculation

IMGT's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	49999.595	/	6403.395
	=	7.81

IMGT's current Enterprise Value is ₩49,999.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IMGT's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩6,403.40 Mil.

IMGT (XKRX:456570) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

IMGT's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	6403.395	/	32135.9963
	=	19.93 %

IMGT's Enterprise Value for the quarter that ended in Dec. 2023 was ₩32,136.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. IMGT's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩6,403.40 Mil.

IMGT EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of IMGT's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT (XKRX:456570) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605

Website

http://www.imgt.co.kr

IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines